Hristos Polymeropoulos Mihael's Insider Trades & SAST Disclosures
Hristos Polymeropoulos Mihael's most recent trade in Vanda Pharmaceuticals Inc was a trade of 5,000 Common Stock done at an average price of $5.0 . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Hristos Polymeropoulos Mihael.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 5.02 per share. | 06 Mar 2025 | 5,000 | 2,290,731 (4%) | 0% | 5.0 | 25,100 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 5.01 per share. | 06 Mar 2025 | 5,000 | 2,295,731 (4%) | 0% | 5.0 | 25,050 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 5.03 per share. | 05 Mar 2025 | 5,000 | 2,285,731 (4%) | 0% | 5.0 | 25,150 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 5.01 per share. | 05 Mar 2025 | 5,000 | 2,280,731 (4%) | 0% | 5.0 | 25,050 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 01 Mar 2025 | 95,999 | 2,265,731 (4%) | 0% | 4.8 | 456,955 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.70 per share. | 01 Mar 2025 | 10,000 | 2,275,731 (4%) | 0% | 4.7 | 47,050 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.76 per share. | 28 Feb 2025 | 10,000 | 2,361,730 (4%) | 0% | 4.8 | 47,600 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.76 per share. | 27 Feb 2025 | 10,000 | 2,351,730 (4%) | 0% | 4.8 | 47,600 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.78 per share. | 26 Feb 2025 | 5,000 | 2,341,730 (4%) | 0% | 4.8 | 23,900 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 26 Feb 2025 | 5,000 | 2,336,730 (4%) | 0% | 4.8 | 23,750 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.46 per share. | 25 Feb 2025 | 10,000 | 2,331,730 (4%) | 0% | 4.5 | 44,640 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 450,000 | 2,321,730 (4%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 4.24 per share. | 04 Mar 2024 | 30,884 | 1,896,018 (3%) | 0% | 4.2 | 131,066 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 4.13 per share. | 04 Mar 2024 | 24,288 | 1,871,730 (3%) | 0% | 4.1 | 100,273 | Common Stock |
| Vanda Pharmaceuticals Inc | Hristos Polymeropoulos Mihael | Director, President and CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 450,000 | 1,926,902 (3%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 6.25 per share. | 02 Mar 2023 | 22,538 | 1,476,902 (2%) | 0% | 6.3 | 140,876 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 6.23 per share. | 02 Mar 2023 | 22,426 | 1,499,440 (2%) | 0% | 6.2 | 139,718 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 115,000 | 1,521,866 (2%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. | 05 Dec 2022 | 75,365 | 1,455,116 (2%) | 0% | 3.1 | 235,139 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2022 | 75,365 | 0 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. | 05 Dec 2022 | 74,635 | 1,427,401 (2%) | 0% | 3.1 | 232,861 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2022 | 74,635 | 75,365 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 10.61 per share. | 05 Dec 2022 | 48,250 | 1,406,866 (2%) | 0% | 10.6 | 512,082 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 10.62 per share. | 05 Dec 2022 | 47,650 | 1,379,751 (2%) | 0% | 10.6 | 506,200 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 115,000 | 1,389,862 (2%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 11.15 per share. | 28 Feb 2022 | 29,588 | 1,352,766 (2%) | 0% | 11.2 | 329,945 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 11.19 per share. | 28 Feb 2022 | 7,508 | 1,382,354 (2%) | 0% | 11.2 | 84,015 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.88 per share. | 30 Nov 2021 | 78,324 | 1,299,386 (2%) | 0% | 4.9 | 382,221 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 78,324 | 71,676 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 71,676 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.88 per share. | 30 Nov 2021 | 71,676 | 1,321,062 (2%) | 0% | 4.9 | 349,779 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.49 per share. | 30 Nov 2021 | 50,000 | 1,249,386 (2%) | 0% | 16.5 | 824,275 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 30 Nov 2021 | 46,200 | 1,274,862 (2%) | 0% | 16.0 | 739,348 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 08 Mar 2021 | 175,000 | 1,221,062 (2%) | 0% | 18.0 | 3,150,053 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.34 per share. | 01 Mar 2021 | 15,206 | 1,396,062 (2%) | 0% | 18.3 | 278,902 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.45 per share. | 01 Mar 2021 | 7,479 | 1,411,268 (2%) | 0% | 18.5 | 138,003 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 275,000 | 275,000 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 115,000 | 1,418,747 (2%) | 0% | - | Common Stock | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2020 | 61,520 | 46,663 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.75 per share. | 11 Dec 2020 | 61,520 | 1,347,283 (2%) | 0% | 8.8 | 538,300 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.19 per share. | 11 Dec 2020 | 51,049 | 1,296,234 (2%) | 0% | 13.2 | 673,306 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2020 | 46,663 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.75 per share. | 11 Dec 2020 | 46,663 | 1,342,897 (2%) | 0% | 8.7 | 408,301 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.75 per share. | 11 Dec 2020 | 41,817 | 1,320,816 (2%) | 0% | 8.8 | 365,899 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2020 | 41,817 | 108,183 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 11 Dec 2020 | 39,150 | 1,303,747 (2%) | 0% | 13.0 | 508,844 | Common Stock |
| Vanda Pharmaceuticals Inc | Mihael Hristos Polymeropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 12.88 per share. | 11 Dec 2020 | 35,053 | 1,285,763 (2%) | 0% | 12.9 | 451,360 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges